Dan Roden
Faculty Member
Last active: 2/8/2016

  1. Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Müller II, Melville DB, Tanwar V, Rybski WM, Mukherjee A, Shoemaker MB, Wang WD, Schoenhard JA, Roden DM, Darbar D, Knapik EW, Hatzopoulos AK (2013) Dis Model Mech 6(2): 332-41
    › Primary publication · 23223679 (PubMed) · PMC3597016 (PubMed Central)
  2. Ethical and practical challenges to studying patients who opt out of large-scale biorepository research. Rosenbloom ST, Madison JL, Brothers KB, Bowton EA, Clayton EW, Malin BA, Roden DM, Pulley J (2013) J Am Med Inform Assoc 20(e2): e221-5
    › Primary publication · 23886923 (PubMed) · PMC3861935 (PubMed Central)
  3. Enabling genomic-phenomic association discovery without sacrificing anonymity. Heatherly RD, Loukides G, Denny JC, Haines JL, Roden DM, Malin BA (2013) PLoS One 8(2): e53875
    › Primary publication · 23405076 (PubMed) · PMC3566194 (PubMed Central)
  4. Electronic health record design and implementation for pharmacogenomics: a local perspective. Peterson JF, Bowton E, Field JR, Beller M, Mitchell J, Schildcrout J, Gregg W, Johnson K, Jirjis JN, Roden DM, Pulley JM, Denny JC (2013) Genet Med 15(10): 833-41
    › Primary publication · 24009000 (PubMed) · PMC3925979 (PubMed Central)
  5. Drug-induced arrhythmia: pharmacogenomic prescribing? Behr ER, Roden D (2013) Eur Heart J 34(2): 89-95
    › Primary publication · 23091201 (PubMed) · PMC3538275 (PubMed Central)
  6. Correction: Enabling Genomic-Phenomic Association Discovery without Sacrificing Anonymity. Heatherly RD, Loukides G, Denny JC, Haines JL, Roden DM, Malin BA (2013) PLoS One 8(6)
    › Primary publication · 23825513 (PubMed) · PMC3691369 (PubMed Central)
  7. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Borggrefe M, Schimpf R, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kääb S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bézieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R (2013) Nat Genet 45(9): 1044-9
    › Primary publication · 23872634 (PubMed) · PMC3869788 (PubMed Central)
  8. Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Parvez B, Shoemaker MB, Muhammad R, Richardson R, Jiang L, Blair MA, Roden DM, Darbar D (2013) Heart Rhythm 10(6): 849-55
    › Primary publication · 23428961 (PubMed) · PMC3690553 (PubMed Central)
  9. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Benjamin Shoemaker M, Muhammad R, Parvez B, White BW, Streur M, Song Y, Stubblefield T, Kucera G, Blair M, Rytlewski J, Parvathaneni S, Nagarakanti R, Saavedra P, Ellis CR, Patrick Whalen S, Roden DM, Darbar R D (2013) Heart Rhythm 10(3): 394-400
    › Primary publication · 23178686 (PubMed) · PMC3587357 (PubMed Central)
  10. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M, Clinical Pharmacogenomics Implementation Consortium (CPIC) (2012) Clin Pharmacol Ther 92(1): 112-7
    › Primary publication · 22617227 (PubMed) · PMC3384438 (PubMed Central)